publicações selecionadas
- A randomized pharmacokinetic and pharmacodynamic trial of two regular human insulins demonstrates bioequivalence in type 1 diabetes and availability of biosimilar insulin may improve access to this medication
- Estudo clínico, cruzado, duplo-cego, randomizado de farmacocinética (PK) e farmacodinâmica (PD) comparando duas insulinas humanas recombinantes Regular, utilizando o CLAMP euglicêmico e hiperinsulinêmico em diabéticos tipo 1
- Transe dissociativo mediúnico: aspectos demográficos, psicopatológicos e marcadores biológicos
- Contemporary (2019) prevalence of cardiovascular disease in adults with type 2 diabetes in Brazil: the cross-sectional CAPTURE study
- Exploring early combination strategy in Latin American patients with newly diagnosed type 2 diabetes: a sub-analysis of the VERIFY study
- Roux-en-Y Gastric Bypass Improves Adiponectin to Leptin Ratio and Inflammatory Profile in Severely Obese Women with and without Metabolic Syndrome: A Randomized Controlled Trial
- 94-LB: Long-Term Clinical Benefits of Early Combination Approach in Latin American Subpopulation of VERIFY Study
- Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type2 Diabetes
- Intensidade da dor após aplicação de somatropina humana recombinante: estudo comparativo de não-inferioridade, randomizado e cruzado
- Acute Effect of Acupuncture on Glycemic Control in Type 2 Diabetes Measured by Continuous Glucose Monitoring: A Pilot Study
- Switching from originator recombinant growth hormone (Genotropin-) to biosimilar (CRISCY-): Results from a 6-month, multicentric, non-inferiority, extension trial.
- AVALIAÇÃO DO EIXO HIPOTÁLAMO-HIPÓFISE-ADRENAL EM INDIVÍDUOS COM E SEM MEDIUNIDADE (EXPERIÊNCIAS ANÔMALAS) EM UM CONTEXTO RELIGIOSO.
- Effects of Roux-en-Y gastric bypass on the metabolic profile and systemic inflammatory status of women with metabolic syndrome: randomized controlled clinical trial
- Capture: a multinational, cross-sectional study of cardiovascular disease in adults with type 2 diabetes across 13 countries
